Four-way comparison

Vardenafil vs Sildenafil vs Tadalafil vs Avanafil: How the Four ED Pills Compare

Avanafil is labeled for the earliest dosing and tadalafil for the longest period of benefit. Here is the full comparison.

ED Treatments Compared editorial team · Updated · 8 min read

Sildenafil, tadalafil, vardenafil and avanafil are the four oral PDE5 inhibitors sold for erectile dysfunction in the US, and they differ mainly in timing, how long they last, food effects and tablet strengths rather than in what they do. Avanafil (Stendra) has the earliest labeled dosing window, at about 15 minutes before sex; tadalafil (Cialis) has the longest labeled period of benefit, up to 36 hours; sildenafil (Viagra) and vardenafil are labeled for roughly an hour ahead.1432 Network meta-analyses disagree on which is strongest, and none of this replaces a clinician choosing among them for a given man's health and medicines.

How do the four labels compare side by side?

The table uses each drug's own FDA label, so the numbers are the manufacturers' tested doses and not head-to-head results.

Sildenafil (Viagra)Tadalafil (Cialis)VardenafilAvanafil (Stendra)
Usual starting dose, as needed50 mg; range 25 to 100 mg110 mg; range 5 to 20 mg410 mg; range 5 to 20 mg2100 mg; range 50 to 200 mg3
Labeled timing before sexAbout 1 hour; may be taken 30 minutes to 4 hours before1"Prior to anticipated sexual activity"; no fixed wait stated4About 60 minutes2As early as about 15 minutes at 100 or 200 mg; about 30 minutes at 50 mg3
Frequency limitOnce per day1Once per day as needed; a separate once-daily 2.5 or 5 mg schedule exists4Up to once daily2No more than once a day3
Period of benefit on the labelNot stated as a durationImproved erectile function versus placebo up to 36 hours after dosing4Not stated as a durationNot stated as a duration
FoodMay be taken with or without food; a high-fat meal delays absorption by about 60 minutes and lowers peak level 29%1Without regard to food4High-fat meals lowered peak level 18% to 50% in two food studies2With or without food; a high-fat meal delayed peak by about 1.1 to 1.3 hours, judged of minimal clinical significance3
Headache in placebo-controlled trials16%, 21% and 28% at 25, 50 and 100 mg, versus 7%111% at 5 and 10 mg and 15% at 20 mg, versus 5%415% versus 4% (all doses pooled)25.1%, 6.9% and 10.5% at 50, 100 and 200 mg, versus 1.7%3
Flushing10%, 19% and 18%, versus 2%12% to 3% versus 1%411% versus 1%23.2%, 4.3% and 4.0%, versus 0%3

Adverse-reaction rates come from different trials with different populations, so differences between columns should not be read as a ranking. Within a drug, rates rise with dose, which is why labels say to use the lowest dose that gives a benefit.3

Which one acts fastest?

On label wording, avanafil. Stendra's label says the 100 mg and 200 mg doses can be taken as early as about 15 minutes before sexual activity, and its pharmacology section reports a median time to peak level of 30 to 45 minutes in the fasted state.3 Viagra's label gives a one-hour target with a 30-minute to 4-hour window, and vardenafil's gives about 60 minutes.12

Tadalafil is the odd one out. Its label sets no wait time for as-needed use. It does report one trial of 223 men in which, at or before 30 minutes after dosing, 35% of the placebo group, 38% on 10 mg and 52% on 20 mg recorded a successful erection, so some men may respond within half an hour, but that is a research measure and not a promise of timing.4 For more on the tadalafil schedule question, see daily versus as-needed tadalafil.

Which one lasts longest?

Tadalafil. The Cialis label reports improved erectile function compared with placebo up to 36 hours after a dose, and a mean terminal half-life of 17.5 hours in healthy volunteers.4 The other three labels do not describe a duration of benefit. That is a real difference in how a man plans around sex. Our sildenafil versus tadalafil comparison goes through that pairing in detail.

What does the research say about which is strongest?

It depends on the analysis, and none is a direct comparison of all four in the same men.

  • 2021 network meta-analysis (Madeira, World J Urol): 179 randomized trials, 50,620 patients. All PDE5 inhibitors beat placebo. Sildenafil 25 mg and 50 mg and tadalafil 10 mg and 20 mg had the highest probabilities of ranking best on IIEF scores, while avanafil was described as a less effective intervention. The authors recommended low-dose sildenafil and tadalafil as first options.5
  • 2026 dose-response network meta-analysis (Salonia, J Sex Med): 83 double-blind placebo-controlled trials, 6,029 participants, only on-demand doses. Odds ratios for reaching satisfactory erectile function versus placebo were 9.06 for sildenafil 100 mg, 7.90 for sildenafil 50 mg, 7.78 for vardenafil 10 mg, 7.13 for tadalafil 20 mg, 3.14 for tadalafil 10 mg, 3.42 for avanafil 200 mg and 1.75 for avanafil 100 mg. Two authors are employed by Viatris, which markets some of these drugs.6

Two things stand out. Avanafil sits lowest in both analyses, though the speed advantage is not what these analyses measure. And at a given drug, dose changes the picture a lot: tadalafil 10 mg and 20 mg are far apart in the 2026 numbers. Network meta-analyses compare drugs indirectly across different trials, so wide differences in design can shift results.

The Stendra label's own placebo-controlled trial in 646 men (mean age 55.7) found successful intercourse attempts of 27.0% on placebo versus 41.3%, 57.1% and 57.0% on 50, 100 and 200 mg at the end of 3 months.3 That is a clear benefit over placebo, and it is a different outcome from the IIEF-based endpoints above, so the figures cannot be lined up against them.

What do all four share?

Every PDE5 inhibitor carries the same core limits. None can be taken with nitrates in any form or with riociguat, and all need extra care with alpha-blockers: the Viagra label says to be stable on the alpha-blocker first and start at 25 mg, and the Stendra label sets a 50 mg starting dose in that case.13 Strong CYP3A4 inhibitors such as ritonavir change the picture sharply. Stendra's label says not to use avanafil with them, and caps it at 50 mg in 24 hours with moderate inhibitors such as erythromycin or diltiazem.3 Taking two PDE5 inhibitors together is not a way around these limits; the Viagra label notes that combinations with other ED treatments have not been studied.1

Seek emergency care for an erection lasting more than 4 hours, and stop and get medical help for sudden vision or hearing loss.13

So how do you choose between them?

These are the questions a clinician is likely to weigh, written as a checklist for the appointment:

  • Spontaneity. A long period of benefit favors tadalafil; a short, defined window favors the others.
  • Timing. If planning ahead is hard, avanafil's 15-minute label window is the shortest, though the high-dose tablets carry more headache in the label trials.3
  • Meals. Heavy, fatty meals slow sildenafil and avanafil and lower vardenafil's peak; tadalafil is labeled for use regardless of food.1423
  • Other conditions. Enlarged prostate symptoms are on tadalafil's label and not the others', and the choice for heart, kidney or liver disease is a clinician's.4
  • Side effects already experienced. Flushing, nasal congestion and headache differ by drug and dose, and a switch of drug or dose is a normal next step.

If one drug disappoints, our sildenafil versus vardenafil and compounded versus FDA-approved guides cover the neighboring questions.

Talk to a clinician. This article explains the evidence; it cannot tell you what is right for you. A licensed clinician who knows your health history and medications can.
Important safety information. PDE5 inhibitors (sildenafil, tadalafil, vardenafil) must not be taken with nitrates in any form, including nitroglycerin, or with guanylate cyclase stimulators such as riociguat, and need caution with alpha-blockers.1 The most common side effects are headache and flushing.1 An erection lasting more than four hours needs emergency care, and sudden loss of vision or hearing means stopping and getting medical help right away.4 Only a licensed clinician who knows your health history and medications should decide whether these are safe for you.

Frequently asked questions

Which ED pill acts fastest?

On label wording, avanafil (Stendra): its 100 mg and 200 mg doses can be taken as early as about 15 minutes before sexual activity. Sildenafil and vardenafil are labeled for about an hour before.

Which ED pill lasts the longest?

Tadalafil. The Cialis label reports improved erectile function compared with placebo up to 36 hours after dosing. The other three labels do not state a duration.

Is avanafil weaker than sildenafil?

In the two network meta-analyses reviewed here avanafil ranked lowest of the four, but those compare trials indirectly and its labeled advantage is early dosing, not a stronger effect.

Does food change how each ED pill acts?

A high-fat meal delays sildenafil absorption by about an hour and lowers its peak level 29%; tadalafil is labeled for use without regard to food. Vardenafil and avanafil also show lower or later peaks with fatty meals.

Can I take two ED pills together?

No. The Viagra label says combinations with other ED treatments have not been studied, and all four carry the same nitrate and blood pressure warnings. A clinician decides.

More comparisons

Part of our guide: ED Pills Compared: Sildenafil, Tadalafil, Vardenafil and Avanafil

Sources

  1. Pfizer. VIAGRA (sildenafil citrate) prescribing information. DailyMed, U.S. National Library of Medicine.
  2. Teva Pharmaceuticals USA. Vardenafil hydrochloride tablets prescribing information. DailyMed, U.S. National Library of Medicine.
  3. Metuchen Pharmaceuticals. STENDRA (avanafil) prescribing information. DailyMed, U.S. National Library of Medicine.
  4. Eli Lilly. CIALIS (tadalafil) prescribing information. DailyMed, U.S. National Library of Medicine.
  5. Madeira CR, et al. Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis. World J Urol. 2021. PubMed 32388784.
  6. Salonia A, et al. A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials. J Sex Med. 2026. PubMed 42296271.